Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gautam Sanyal

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
NPJ Vaccines|May 5, 2022
Development of functionally relevant potency assays for monovalent and multivalent vaccines delivered by evolving technologiesGautam Sanyal
NPJ Vaccines|June 11, 2025
Establishing correlation between in vitro potency and in vivo immunogenicity for mRNA vaccinesGautam Sanyal
Expert Opinion on Therapeutic Patents|May 16, 2009
A review of multiple approaches towards an improved hepatitis B vaccineGautam Sanyal, Li Shi
Expert Opinion on Drug Discovery|March 31, 2012
Bacterial DNA replication enzymes as targets for antibacterial drug discoveryGautam Sanyal, Peter Doig
Journal of Pharmaceutical and Biomedical Analysis|November 1, 2005
Applications of mass spectrometry in early stages of target based drug discoveryGejing Deng, Gautam Sanyal
NPJ Vaccines|April 14, 2021
Considerations for bioanalytical characterization and batch release of COVID-19 vaccinesGautam Sanyal, Anna Särnefält, Arun Kumar
AAPS Pharmscitech|September 16, 2016
Analytical Characterization of an Oil-in-Water Adjuvant EmulsionJenny Sun, Richard L Remmele, Gautam Sanyal
Journal of Virological Methods|October 7, 2017
In vitro infectivity of oncolytic Newcastle Disease Virus: Correlation between plaque and fluorescent focus assaysBenjamin S Rush, Melissa L Coughlin, Gautam Sanyal
Current Drug Targets|December 31, 2011
Applications of biophysical tools to target-based discovery of novel antibacterial leadsSushmita Lahiri, Steven Kazmirski, Gunther Kern, et al.
Journal of Virology|September 4, 2020
Ionic Strength-Dependent, Reversible Pleomorphism of Recombinant Newcastle Disease VirusBenjamin S Rush, Matieyendou Didier Djagbare, Jeffrey A Speir, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
NPJ Vaccines|May 5, 2022
Development of functionally relevant potency assays for monovalent and multivalent vaccines delivered by evolving technologiesGautam Sanyal
NPJ Vaccines|June 11, 2025
Establishing correlation between in vitro potency and in vivo immunogenicity for mRNA vaccinesGautam Sanyal
Expert Opinion on Therapeutic Patents|May 16, 2009
A review of multiple approaches towards an improved hepatitis B vaccineGautam Sanyal, Li Shi
Expert Opinion on Drug Discovery|March 31, 2012
Bacterial DNA replication enzymes as targets for antibacterial drug discoveryGautam Sanyal, Peter Doig
Journal of Pharmaceutical and Biomedical Analysis|November 1, 2005
Applications of mass spectrometry in early stages of target based drug discoveryGejing Deng, Gautam Sanyal
NPJ Vaccines|April 14, 2021
Considerations for bioanalytical characterization and batch release of COVID-19 vaccinesGautam Sanyal, Anna Särnefält, Arun Kumar
AAPS Pharmscitech|September 16, 2016
Analytical Characterization of an Oil-in-Water Adjuvant EmulsionJenny Sun, Richard L Remmele, Gautam Sanyal
Journal of Virological Methods|October 7, 2017
In vitro infectivity of oncolytic Newcastle Disease Virus: Correlation between plaque and fluorescent focus assaysBenjamin S Rush, Melissa L Coughlin, Gautam Sanyal
Current Drug Targets|December 31, 2011
Applications of biophysical tools to target-based discovery of novel antibacterial leadsSushmita Lahiri, Steven Kazmirski, Gunther Kern, et al.
Journal of Virology|September 4, 2020
Ionic Strength-Dependent, Reversible Pleomorphism of Recombinant Newcastle Disease VirusBenjamin S Rush, Matieyendou Didier Djagbare, Jeffrey A Speir, et al.
Pageof 3